India: Jubilant Life Sciences exploring Singapore IPO for pharma unit

India: Jubilant Life Sciences exploring Singapore IPO for pharma unit

Jubilant Life Sciences Ltd., a roughly $2 billion India-based drug company, is considering a Singapore initial public offering of its pharmaceuticals subsidiary, according to people with knowledge of the matter.

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief
Subscribe to Newsletter